Weinstein J, Lee EU,

McEntee K, Lai PH, Paulson JC: Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor. J Biol Chem 1987,262(36):17735–17743.PubMed 13. Lin S, Kemmner W, Grigull S, Schlag PM: Cell surface [alpha] 2, 6-sialylation affects adhesion of breast carcinoma cells. Exp Cell Res 2002,276(1):101–110.PubMedCrossRef 14. Kemmner W, Hohaus K, Schlag PM: Inhibition of Gal [beta] 1, 4GlcNAc [alpha] 2, 6 sialyltransferase expression by antisense-oligodeoxynucleotides. FEBS Lett 1997,409(3):347–350.PubMedCrossRef 15. Zheng B, Guan Y, Tang Q, Du C, Xie FY, He ML, Chan KW, Wong KL, Lader E, Woodle MC: Prophylactic and LY3023414 cost therapeutic effects of small interfering RNA targeting SARS coronavirus. Antivir Ther 2004,9(3):365–374.PubMed 16. Zielske SP, Stevenson M: Modest but reproducible inhibition of human selleck chemical immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol 2006,80(14):7275–7280.PubMedCentralPubMedCrossRef check details 17. Joost Haasnoot P, Cupac D, Berkhout B: Inhibition of virus replication by RNA interference. J Biomedic Sci 2003,10(6):607–616.CrossRef 18. Li B, Tang Q, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu Y, Zheng B,

Woodle MC: Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nature Med 2005,11(9):944–951.PubMed 19. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J: RNA interference of influenza virus production by directly targeting mRNA for degradation and

indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci 2003,100(5):2718–2723.PubMedCentralPubMedCrossRef 20. Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J: Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A 2004,101(23):8676.PubMedCentralPubMedCrossRef 21. Prabhu N, Prabakaran M, Hongliang Q, He F, Ho HT, Qiang J, Goutama M, Flucloronide Lim A, Hanson BJ, Kwang J: Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza. Antivir Ther 2009,14(7):911–921.PubMedCrossRef 22. Nicholls JM, Peiris JS, Guan Y: Sialic acid and receptor expression on the respiratory tract in normal subjects and H5N1 and non-avian influenza patients. Hong Kong Med J 2009,15(3 Suppl 4):16–20.PubMed 23. Ge Q, Eisen HN, Chen J: Use of siRNAs to prevent and treat influenza virus infection. Virus Res 2004,102(1):37–42.PubMedCrossRef 24. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 2004,101(7):1892.PubMedCentralPubMedCrossRef 25.